BioForce Nanosciences Exceeds Goal for Shipping Nano eNabler Printers

BioForce Nanosciences has announced that it exceeded its 2006 goal for shipping up to 20 of its cutting-edge Nano eNabler molecular printers to prestigious institutions across the globe. BioForce exceeded its goal by two units by year end. These pilot placements of the Company's patented Nano eNabler device at centers of research excellence, allow the entrepreneurial researchers at those centers to act as "early adopters" of BioForce's practical tools and technologies.

"With the shipment of these 22 Nano eNabler molecular printers," says BioForce Product Manager Michael Lynch, "BioForce is now essentially partnering with an impressive group of innovators working in the micro and nanotechnology fields. Several groups have already expressed a desire to seek funds to convert their placement into a purchase."

Kerry Frey, BioForce's chief operating officer, says, "BioForce Nanosciences is positioned between two very exciting markets-nanotechnology and the life sciences. We strongly believe our Nano eNabler system will change how research is conducted in laboratories across the world." He explains that the ease of use and practicality provided by the Nano eNabler system, establish a path from laboratory to industry.

Institutions where recent placements have taken place:

  • University of California, Cal-it2, Irvine, CA
  • Cornell University, NanoBioTechnology Center, Ithaca, NY
  • ETH Zurich, Zurich, Switzerland
  • Georgia Institute of Technology, Microelectronics Research Center, Atlanta, GA
  • Stanford University, James H. Clark Center, Stanford, CA

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.